Major aryl hydrocarbon
receptor (AhR) agonists were identified
in extracts of blubber, liver, and muscle from six long-beaked common
dolphins (Delphinus capensis) and one fin whale (Balaenoptera physalus) collected from Korean coastal waters
using effect-directed analysis. Results of the H4IIE-luc bioassay indicated that the polar fractions of blubber and liver
extracts from the fin whale exhibited relatively high AhR-mediated
potencies. Based on full-scan screening with high-resolution mass
spectrometry, 37 AhR agonist candidates, spanning four use categories:
pharmaceuticals, pesticides, cosmetics, and natural products, were
selected. Among these, five polar AhR agonists were newly identified
through toxicological confirmation. Concentrations of polar AhR agonists
in cetaceans were tissue-specific, with extracts of blubber and liver
containing greater concentrations than muscle extracts. Polar AhR
agonists with great log K
OA values (>5)
were found to biomagnify in the marine food chain potentially. Polar
AhR agonists contributed 8.9% of the observed AhR-mediated potencies
in blubber and 49% in liver. Rutaecarpine and alantolactone contributed
significantly to the total AhR-mediated potencies of blubber, whereas
hydrocortisone was a major AhR contributor in the liver of the fin
whale. This study is the first to identify the tissue-specific accumulation
of polar AhR agonists in blubber and liver extracts of cetaceans.